High TMAO levels promoted the elevation of plasma osmotic pressure, increasing the secretion of arginine vasopressin (AVP) from the posterior pituitary
Moreover, a recent meta-analysis illustrated a significant reduction in weight and WC due to synbiotic supplementation (55)
For patients with recurrent vulvovaginal candidiasis (four or more episodes annually), management should include: Microscopy and culture to identify the Candida species An induction-maintenance regimen (e.g., fluconazole 150mg every 72 hours for three doses, followed by weekly maintenance for up to six months) Thorough review of predisposing factors Management strategies for patients on Ozempic should include: Optimising glycaemic control as the cornerstone of preventionreviewing HbA1c targets and adjusting diabetes medications as needed Completing the full course of antifungal treatment even if symptoms resolve early Treating sexual partners if they have symptoms (though routine partner treatment is not necessary for uncomplicated cases) Reviewing and addressing modifiable risk factors Considering prophylactic antifungal therapy for patients with frequent recurrences Patients should be reassured that yeast infections, whilst uncomfortable, are treatable and that continuing Ozempic is appropriate provided diabetes control is optimised
Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Do not double doses.
Breaking the cycle requires addressing both the hormonal deficit and the excess fat simultaneously
